obeticholic acid
Commercial- Indications
- Primary biliary cholangitis
Company intelligence / Profile preview
Intercept Pharmaceuticals
Morristown, New Jersey, United Statesinterceptpharma.com ↗
- Ownership
- Public · ICPT
- Employees
- ~341
- Development stage
- Commercial
01
Overview
Intercept's lead product Ocaliva (obeticholic acid) is approved for primary biliary cholangitis. The company is conducting Phase 2 studies (747-213 and 747-214) exploring therapeutic doses for the combination of OCA and bezafibrate. They also have a Phase 2a FRESH study for INT-787 in severe alcohol-associated hepatitis.
- Therapeutic areas
- Gastroenterology
- Modalities
- Small moleculesbile acid analogs
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Tes Pharma (renewed R&D partnership in January 2025)Aralez Pharmaceuticals Canada Inc. (license agreement for bezafibrate development)
04
Financials
- Market cap
- $794.7M
- Total revenue
- $88.8M
- Enterprise value
- $695.8M
Beyond the preview
Go deeper on Intercept Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intercept Pharmaceuticals.